B
DPLO

Baird’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Baird’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$866K Buy
25,035
+3,014
+14% +$82K 0.01% 788
2014
Q4 		$603K Buy
+22,021
New +$534K 0.01% 883

Other funds holding DPLO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baird's DPLO Position: Q1 2015 in Review

Baird increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 14% in Q1 2015, buying an estimated $82K and bringing the position to 25,035 shares worth $866K. The position accounts for 0.01% of the portfolio, ranked #788.

Baird first reported a position in DPLO in Q4 2014 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold DPLO as of Q1 2015.

  • Baird held 25,035 shares of DIPLOMAT PHARMACY, INC. worth $866K as of Q1 2015.
  • Baird bought 3,014 DIPLOMAT PHARMACY, INC. shares in Q1 2015, an estimated $82K.
  • DIPLOMAT PHARMACY, INC. made up 0.01% of Baird's portfolio in Q1 2015, its #788 holding.
  • Baird first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.